Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
12.54 EUR | +1.13% | +12.97% | +74.17% |
Apr. 17 | Medincell: share price rises following agreement with AbbVie | CF |
Apr. 16 | Medincell, AbbVie to Co-Develop Injectable Therapeutics | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+74.17% | 382M | |
+24.91% | 556B | |
-6.33% | 354B | |
+19.90% | 331B | |
+7.95% | 296B | |
+13.51% | 233B | |
+5.63% | 201B | |
-10.14% | 193B | |
-12.26% | 143B | |
-6.47% | 144B |
- Stock Market
- Equities
- MEDCL Stock
- News MedinCell S.A.
- MedinCell S A : , Teva Eye US Launch Of Schizophrenia Therapy In 2022